In order to ensure ease of doing pharmacovigilance (PV) practices by the industry, the Union health ministry has finally come out with PV guidelines for Market Authorisation Holders (MAHs) after due deliberations with the stakeholders. Post-release, market authorisation holders will be given six months time to implement the guidelines. Apart from facilitating harmonisation in adverse […]
Friday, September 22, 2017, 08:00 Hrs [IST] In order to equip and sensitise Indian pharma companies to set up pharmacovigilance (PV) cells for generating adverse drug reaction (ADR) data, Ghaziabad based Indian Pharmacopoeia Commission (IPC) under the Union health ministry conducted workshops in Bengaluru and Hyderabad in the first week of September 2017 to help companies […]
Applications are invited for 6 weeks extensive hands on training on aggregate report writing including PSUR/PBRER. The seats are limited and selection is based on….
Applications are invited from graduates in Pharmacy, Nursing, Medical and other Life Sciences for admission in 2 years masters degree in Pharmacovigilance.